Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...

A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment.

Scientists at MIT have identified 24 protein fragments that could form a new tuberculosis vaccine, offering a potential breakthrough. This next-genera ...

Initial blood work found hints of an infection, and the doctors initially suspected a bacterial skin infection (cellulitis) ...

The World Health Organization praised India for making notable progress in tuberculosis detection and treatment, although the ...

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...

By Sharon Atieno With tuberculosis (TB) treatment lasting about six to nine months, a new treatment regimen is set to reduce this period.A phase two clinical trial by TB Alliance has showed that a new ...

A new study published in PLOS Global Public Health contributes to the growing evidence that nutrition should be treated as a core part of tuberculosis care—not an afterthought. The research, conducted ...